CA SCR148

GM1 Gangliosidosis Awareness Day.

Passed Senate Steve Padilla (D)
Plain English Summary

CA SCR148 establishes a day dedicated to raising awareness about GM1 Gangliosidosis, a rare genetic disorder. The bill aims to inform the public about the condition, its impact on individuals and families, and the importance of research and support for those affected. By designating this awareness day, California seeks to promote understanding and advocacy for better resources and treatments.

Supporters Say

Supporters of CA SCR148 would highlight the importance of raising awareness for GM1 Gangliosidosis, emphasizing that increased public knowledge can lead to better support for affected families. They would argue that this initiative encourages research funding and fosters a community of understanding and compassion for those living with the condition. By recognizing this day, California positions itself as a leader in addressing rare diseases.

Critics Say

Critics of CA SCR148 might argue that while raising awareness is important, it may divert attention and resources from more pressing health issues that affect a larger number of people. They could contend that designating awareness days can become symbolic rather than leading to substantive action or funding for research. Additionally, some may feel that the bill does not address the practical needs of families dealing with GM1 Gangliosidosis.

Legislative Votes
SCR 148 Padilla Consent Calendar Second Day Regular Session
A · May 21, 2026
Passed
68
YEA
0
NAY
Be adopted. To Consent Calendar
A · May 18, 2026
Passed
9
YEA
0
NAY
Senate 3rd Reading SCR148 Padilla et al
Senate · May 11, 2026
Passed
39
YEA
0
NAY

Source: LegiScan roll call vote data.

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us

About This Analysis

This summary was generated using AI from the bill's official text and metadata. Data sourced from LegiScan and the California State Legislature. Conflict-of-interest analysis for this bill is coming soon.